Frequency determination of breast tumor-reactive CD4 and CD8 T cells in humans: unveiling the antitumor immune response
As cancer immunotherapy gains importance, the determination of a patient’s ability to react to his/her tumor is unquestionably relevant. Though the presence of T cells that recognize specific tumor antigens is well established, the total frequency of tumor-reactive T cells in humans is difficult to...
Main Authors: | Mariana Pereira Pinho, Thiago Andrade Patente, Elizabeth Alexandra Flatow, Federica Sallusto, José Alexandre Marzagão Barbuto |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-08-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2019.1607674 |
Similar Items
-
Polyploidy Spectrum Correlates with Immunophenotype and Shapes Hepatocellular Carcinoma Recurrence Following Liver Transplantation
by: Zhang L, et al.
Published: (2022-01-01) -
Commentary: Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells
by: Mariana Pereira Pinho, et al.
Published: (2018-11-01) -
CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production
by: Kwangmin Na, et al.
Published: (2024-03-01) -
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy
by: Nicola Principe, et al.
Published: (2020-11-01) -
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
by: Aurélie Durgeau, et al.
Published: (2018-01-01)